Stephen Sheller was quoted in a July 31, 2015 article discussing Risperdal research that was “manipulated by a drug company and understated the risks of a powerful antipsychotic used to treat kids with behavioural problems.”
In the news story, pediatrician Denis Daneman says there was no intent on his part to exclude “significant results” from a research study he had participated in that was published in a medical journal regarding the antipsychotice drug Risperdal and its use in children.
Link
Drug company accused of altering study by top SickKids pediatrician, The Toronto Star, July 31, 2015
